The Effect of Nimodipine Monotherapy and Combined Treatment with Ketamine and Lignocaine in Aneurysmal Subarachnoid Haemorrhage

Abstract

The clinical effects of nimodipine monotherapy were compared with the effects of nimodipine combined with ketamine and lignocaine (combination therapy) in a single-centre, one investigator, open study in patients with proven aneurysmal subarachnoid haemorrhage (aSAH). After clipping of the aneurysm, nimodipine was administered intravenously until day 5 – 7 after clipping. Thereafter the intravenous nimodipine was substituted by oral doses of nimodipine. These were decreased gradually and then discontinued within the following 6 days. For combination therapy, nimodipine was given together with both a bolus injection of 1 μg/kg ketamine followed by an infusion of the drug at a rate of 3 μg/kg/min and a bolus injection of 1.5 mg/kg lignocaine followed by an infusion of the drug at a rate of 12 μg/kg/min. During the study period, 173 patients were admitted to the hospital with subarachnoid haemorrhage (SAH). Of these patients, 115 with a proven aneurysm were operated on and evaluated: 66 patients received nimodipine monotherapy and 49 were given nimodipine combined with ketamine and lignocaine. These subgroups were comparable in terms of the baseline characteristics (age, Hunt and Hess score). The (baseline corrected) Hunt and Hess scores after surgery and a 0 – 5 clinical outcome score were applied as indices for clinical effects. Patients receiving nimodipine monotherapy and combined therapy showed a significant clinical improvement compared to baseline (P = 0.001 and P = 0.006, respectively). The beneficial effect of nimodipine monotherapy is in line with previous double-blind, placebo-controlled studies. Although nimodipine monotherapy seems to be more effective than combined treatment, this was not statistically significant. Our data indicate that combined treatment with ketamine and lignocaine is not more effective than nimodipine monotherapy in patients with mild aSAH, but this does not rule out an effect in severe cases. There was no indication of a pharmacodynamic interaction between nimodipine and co-medication. No serious or clinically relevant adverse reactions were noted during the study.

Keywords

Aneurysm Ketamine Lignocaine Nimodipine Subarachnoid haemorrhage

Get full access to this article

View all access options for this article.

References

Pickard

Murray

Illingworth

: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage. British Aneurysm Nimodipine Trial. BMJ 1989; 298: 636–642.

Allen

Arm

Preziosi

: Cerebral arterial spasm. A controlled trial of nimodipine in patients with subarachnoid haemorrhage. N Engl J Med 1983; 308: 619–624.

Öhman

Heiskanen

: Effects of nimodipine on the outcome of patients after aneurysmal subarachnoid haemorrhage and surgery. J Neurosurg 1988; 69: 683–686.

Philippon

Grob

Dagreou

: Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochir 1986; 82: 110–114.

Neil-Dwyer

Mee

Dorrance

: Early intervention with nimodipine in subarachnoid haemorrhage. Eur Heart J 1987; 8 (suppl. K): 41–48

Greenamyre

: The role of glutamate in neurotransmission and in neurologic disease. Arch Neurol 1986; 43: 1058–1062.

Anis

Berry

Burton

: The dissociation anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-D-aspartate. Br J Pharmacol 1983; 79: 565–575.

Fukuda

: Direct effects of ketamine on isolated canine cerebral and mesenteric arteries. Anaesth Analg 1983; 62: 553–558.

Gelmers

: Effect of nimodipine on the cerebral circulation and acute ischaemic stroke. In: New Trends in Diagnosis and Management of Stroke (Poeck K, Ringelstein EB, Hacke W, eds) Springer Verlag, 1987; pp 135–142.

10.

Evans

: Protective effect of lidocaine in acute cerebral ischaemia induced by air embolism. J Neurosurg 1984; 60: 257–263.

11.

Cassuto

: Inhibition of postoperative pain by continuous low-dose intravenous infusion of lidocaine. Anaesth Analg 1985; 64: 971–974.

12.

White

: Ketamine – its pharmacology and therapeutic uses. Anesthesiology 1982; 56: 119–136.

13.

Downes

: I.V. lignocaine in reflex and allergic bronchoconstriction. Br J Anaesth 1980; 52: 873–878.

14.

Barker

Nimmo

: Althesin, ketamine and lignocaine infusion for neurosurgery. Br J Anaesth 1984; 56: 1309–1310.

15.

Hunt

Hess

: Surgical risk as related to the time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968; 28: 14–20.

16.

Jennett

Bond

: Assessment of outcome after severe brain damage. A practical scale. Lancet 1975; 1: 480–484.

17.

Wadworth

McTavish

: Nimodipine. A review of its pharmacological properties, and therapeutic efficacy in cerebral disorders. Drugs Aging 1992; 2: 262–286.

18.

Dorsch

NWC

: A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage. Part III: mechanism of action of calcium antagonists. J Clin Neurosc 1994; 1: 151–160.

19.

Rothman

Olney

: Glutamate and the pathophysiology of hypoxic-ischaemic brain damage. Ann Neurol 1986; 19: 105–110.

20.

Kassell

Torner

: The international cooperative study on the timing of aneurysm surgery. Part 1: Overall management results. J Neurosurg 1990; 73: 18–36.

21.

Kassell

Torner

: The international cooperative study on the timing of aneurysm surgery. Part 2: Surgical results. J Neurosurg 1990; 73: 37–47.